Invirase (Saquinavir)

The Basics | News | Research

Show Archived (Historical) Articles

Brand Name:	Fortovase	Invirase
Generic Name:	Saquinavir, SQV-SGC	Saquinavir, mesylate, SQV-HGC
Adult Single Dose:	Six 200-mg capsules (three times a day) OR five 200-mg capsules (twice a day) plus one 100-mg ritonavir capsule (twice a day)	Five 200-mg capsules (twice a day) plus one 100-mg ritonavir capsule (twice a day)
Food & Liquid Restrictions:	Take with a meal or up to two hours after a meal	Take up to two hours after a full meal
Drug Class:	PI	PI

The Basics

An Overview of Invirase (Saquinavir) (Regularly Updated)
From AIDSinfo
Saquinavir (Invirase) (February 23, 2010)
To read PDF, click here.
From AIDS InfoNet
Invirase (March/April 2009)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Invirase (Saquinavir) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Invirase (Saquinavir) Patient Product Information (PDF) (July 2007)
From Roche
Patient Information About Invirase (Saquinavir) (PDF) (July 2007)
From Roche
Saquinavir (Fortovase) Fact Sheet (August 15, 2006)
From AIDS Treatment Data Network
Saquinavir (Invirase) (August 15, 2006)
From AIDS Treatment Data Network

News

New FDA Warning on HIV Drugs Invirase and Norvir (February 24, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Ongoing Safety Review of Invirase (Saquinavir) and Possible Association With Abnormal Heart Rhythms (February 23, 2010)
From U.S. Food and Drug Administration
Recent Updates to Invirase Package Insert (June 11, 2008)
From U.S. Food and Drug Administration
Dear Dr. Letter: Fortovase (Saquinavir) Discontinuation Notice (PDF) (May 2005)
From Roche

My Health Tracker

Join Us on Facebook

Widgets and RSS Feeds

U.S. ASO Finder

CROI 2010 Wrap-Up: The HIV Drug Development Pipeline

CROI 2010 Wrap-Up: The Evolution of Antiretroviral Therapy

This Positive Life: An Interview With Gary

HIV Vaccine Trial Lessons: What Researchers Learned From the STEP Study's Failure and the RV144 ("Thai") Study's Success

Why There's Such an HIV/AIDS Disparity Among U.S. Blacks and Hispanics -- and What to Do About It

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.